PPARG and neoplasm: PPZ023 (1-(2-(ethylthio)benzyl)-4-(2-methoxyphenyl)piperazine), a novel peroxisome proliferator-activated receptor gamma (PPARγ) ligand candidate, has a powerful anticancer effect against tumor growth.